Importance of Oral Inflammations for the Healthcare System
Inflammations in the oral cavity such as periodontitis, peri-implant mucositis, or mucosal lesions affect a large portion of the population, especially older and chronically ill individuals. Despite their high prevalence, the impact of these conditions on overall health is often underestimated. The World Health Organization (WHO) counts periodontal diseases among the most common chronic conditions worldwide. Their effects extend beyond the oral area, as there are established links with cardiovascular diseases and blood sugar control in diabetes. Products for treating oral inflammations therefore make a significant contribution to systemic healthcare.
CANNEFF® DNT GEL as a Targeted Solution for Oral Inflammations
CANNEFF® DNT GEL is a modern, CE-certified medical device for the targeted treatment of inflammatory and painful changes of the oral mucosa. It addresses a clinically relevant syndrome occurring in the context of gingivitis, mucositis, mucosal lesions, or postoperative wound healing processes. The patented combination of cannabidiol (CBD) and squalane exerts antimicrobial and anti-inflammatory effects without the need for antibiotics. This makes the gel suitable both for dental use and for daily self-treatment at home.
Contribution to the National AMR Strategy: Effectiveness Without Antibiotics
Reducing antibiotic use is a central concern of the Austrian healthcare system within the framework of the national AMR strategy. Austria is involved in several EU-wide initiatives to combat antimicrobial resistance. CANNEFF® DNT GEL offers an evidence-based antimicrobial alternative. Its effect is achieved without antibiotics, actively supporting the goals of AMR control—especially in dentistry, where systemic antibiotic administration should often be avoided.
Clinical Evidence and Therapeutic Benefit
The effectiveness of CANNEFF® DNT GEL has so far been demonstrated in two clinical studies. These showed significant relief of gingivitis, mucositis, and postoperative mucosal damage. Particularly noteworthy is its potential to prevent periodontitis. Due to its good tolerability, the gel is ideal for daily use, for example in implant care, for aphthae, to prevent periodontitis, or for aftercare following dental procedures.
Market Potential in Austrian Primary Care
With around 5,000 practicing dentists, dentistry is an important part of Austrian primary care. At the same time, self-medication through pharmacies is gaining increasing importance. CANNEFF® DNT GEL is optimally suited for both areas. It can be recommended by doctors or obtained over the counter. As a CE-certified Class IIa medical device, it meets all regulatory requirements and has proven efficacy, safety, and acceptance among patients.
